We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sets Compliance Framework for Compounding Near Replicas of Approved Drugs
FDA Sets Compliance Framework for Compounding Near Replicas of Approved Drugs
The FDA is laying out compliance parameters for outsourcing facilities that compound near replicas of approved drugs, urging them not to distribute such products to patients that could use an approved drug.